Health Care

Inside the fall of 23andMe

Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what happened?

adminadmin
Oct 24, 2024 - 04:00
 0  8
Inside the fall of 23andMe
Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq. So what happened?
Read More

Tags:

Previous Article

Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use

Next Article

Why bond yields are rising and what stock investors should do about that

admin
admin

Related Posts

A corner of the cancer therapy market is heating up—Here are the names investors need to know

A corner of the cancer therapy market is heating up—Her...

admin May 24, 2024  0  20

Delta pauses hot meal service on dozens of Detroit flights citing 'food safety issue' at caterer

Delta pauses hot meal service on dozens of Detroit flig...

admin Oct 14, 2024  0  22

Here are 9 stocks that can benefit from Fed interest rate cuts

Here are 9 stocks that can benefit from Fed interest ra...

admin Jun 13, 2024  0  9